← Back to Search

CAR T-cell Therapy

Long-term Follow-up of CAR T Cell Therapy

Phase 2
Waitlist Available
Research Sponsored by Autolus Limited
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients must have received an AUTO CAR T cell therapy on a clinical treatment study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up for up to 15 years
Awards & highlights
No Placebo-Only Group

Summary

This trial followed patients who received AUTO CAR T cell therapy for up to 15 years after their first treatment.

Who is the study for?
This trial is for patients who have previously received AUTO CAR T cell therapy as part of a clinical study. They must have agreed to long-term follow-up and be able to comply with the study's requirements.
What is being tested?
The trial involves long-term monitoring of patients treated with AUTO CAR T cell therapy, tracking their health for up to 15 years after their first infusion to assess lasting effects and outcomes.
What are the potential side effects?
While specific side effects are not listed, typical ones from CAR T cell therapies may include flu-like symptoms, fatigue, fever, difficulty breathing, confusion or neurological events.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have received CAR T cell therapy as part of a clinical trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~for up to 15 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and for up to 15 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of Serious Adverse Events (SAE), new malignancies & adverse events of special interest (AESI) related to AUTO CAR T cell therapy
Secondary study objectives
Duration of response
Duration of supportive care
Chimeric Antigen Receptor T-Cell Therapy
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: AUTO CAR T cell therapyExperimental Treatment1 Intervention
Patients who received previous treatment with AUTO CAR T Cell Therapy

Find a Location

Who is running the clinical trial?

Autolus LimitedLead Sponsor
7 Previous Clinical Trials
497 Total Patients Enrolled
1 Trials studying Multiple Myeloma
12 Patients Enrolled for Multiple Myeloma
~333 spots leftby Jul 2043
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top